All News

Jan Reichelt, co-founder of Mendeley, reflects on how his start-up brought relief to academics and shook up science publishing. The secret was in making a common cause with fellow researchers, he says

Vytenis Andriukaitis pledges to widen access to innovative healthcare across the EU and to keep the highest health and food safety standards in a more equal ‘Health Union’

Carlos Moedas, Portugal’s nominee for EU Commissioner for research, wins over MEPs. Now it’s time for implementation, implementation, implementation, he says

The German Commissioner is due to switch from energy to the digital portfolio. He wants to put the focus on big picture infrastructure investment, but some of his answers indicate he needs time to get to grip with all the issues

Pharma industry denies it lobbied for medicines to move from health to enterprise directorate

In all, 155 SMEs will receive funding. Along with Spain, the UK and Italy fare well

Young entrepreneurs came face-face-to-face with policymakers in Brussels to talk about taking risks and accepting failure more readily

New innovations like Uber should not be shunned says Eric Schmidt, chairman of Google in his ‘Essay for the European Commission’

The Czechs are accelerating to catch up in the electric car world. However, more government support is needed to help green innovation displace incumbent technologies, saysTomáš Chmelík, project manager for the country’s E-mobility programmme

Next week Jean-Claude Juncker’s new team faces its crucial audition with the European Parliament

Sighs of relief in Switzerland, as the EU accepts its scientists back into a handful of research programmes

With small business nervous about delays in getting paid for EU contracts, failure to find a solution “would seriously put into question the reputation of the EU as a reliable funder of research,” says Máire Geoghegan-Quinn

The lack of innovation portfolios at the top of the new European Commission has a simple solution: name science and innovation advisors to each Vice President

The new Commission goes down well with industry, but environmentalists are less keen

Advocates for cross-sectoral R&D support fear a downgrade in the new Commission – but in individual areas such as energy, digital technologies, and pharmaceuticals, a stronger emphasis on growth and investment is good news for many